The integrity of medical science and practice is being compromised by the profound financial influence of the pharmaceutical industry. An investigation reveals that the American Medical Association (AMA) derives a vast majority of its revenue not from membership dues but from "royalties and credentialing products" purchased primarily by pharmaceutical companies. Furthermore, data shows that drug and device companies have paid billions directly to medical providers, creating pervasive conflicts of interest that can sway prescribing habits. This influence extends deep into medical publishing, with leaders from prestigious journals like The New England Journal of Medicine and The Lancet admitting the system is compromised. Dr. Marcia Angell described how drug companies control research from design to publication, often suppressing negative studies and ensuring only favorable results see the light of day. Richard Horton, editor of The Lancet, stated that perhaps half of all scientific literature may be untrue due to biased studies and flagrant conflicts of interest. With revenue streams like sponsored supplements and paid access to papers, Big Pharma has effectively taken medical journals "hostage," casting serious doubt on whether we can truly trust "the science" related to pharmaceuticals.